Koneksa Health is leveraging the popularity of GLP-1 drugs to study their potential in treating Parkinson’s disease, following promising preliminary research.
An analysis of Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) reveals a disconnect between its recent stock performance and declining revenue. The high price-to-sales ratio warrants further examination.
